Rinvoq (upadacitinib)

pCPA File Number: 21190
Negotiation Status:
Under consideration for negotiation
Indication(s):
Subacute and chronic inflammatory joint diseases
Sponsor/Manufacturer:
AbbVie Corporation
CADTH Project Number:
SR0614-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable